Fig. 4From: Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapyOverview of CRISPR/Cas9-based gene editing of human iPSCs which includes both in vivo and in vitro methods. Gene editing techniques like CRISPR/Cas9 have allowed researchers to develop isogenic control human iPS cell lines to study the genetic pathways underlying disease and cellular functionBack to article page